Noom Med vs TMates: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

52 providers verified independently·Independent research·How we rank →

Visit TMates - our pick of these two→or find your match

TMates beats Noom Med overall, scoring 7.8/10 vs 7.4/10. Noom Med is more affordable at $99/mo vs $158/mo. Choose Noom Med for users who want a tiered entry into glp-1 care, from $99/mo m. Choose TMates for users who want commitment-discount pricing on compounded glp.

A side-by-side look at Noom Med and TMates to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

Noom Med

#27 of 52

7.4/10

Noom restructured Noom Med in 2026 into 3 tiers: $69/mo branded telehealth (med out-of-pocket), $99-149/mo Microdose GLP-1Rx (low-dose + biomarker monitoring), and the Full GLP-1Rx program ($149 intro → $349/mo on 12-week subscription). Coaching app included at every tier.

Visit Noom Med

Higher Rated

TMates

#14 of 52

7.8/10

Telemedicine platform offering two distinct archetypes: compounded semaglutide and tirzepatide with medication included (commitment pricing $158-$249/mo), and a clinical-service-only path to brand-name Wegovy/Zepbound at $99/mo where the prescription is sent to the patient's pharmacy. Phentermine also available. 2026 expansion added brand-name FDA-approved options.

Visit TMates

Feature	Noom Med	TMates
Our Score	7.4/10	7.8/10
Starting Price	$99/mo	$158/mo
Medication Type	Both	Both
Insurance Accepted	Yes	Yes
Best For	Users who want a tiered entry into GLP-1 care, from $99/mo Microdose all-in (low-dose + biomarkers + coaching) up to a full $349/mo medication + coaching program	Users who want commitment-discount pricing on compounded GLP-1s ($158-$249/mo, medication included) or a $99/mo clinical path to brand Wegovy or Zepbound filled at their own pharmacy
Ranking	#27	#14
Get started	Visit Noom Med	Visit TMates

Pros & Cons Compared

Noom Med

Pros

+Tiered 2026 entry, $69/mo branded telehealth tier lets users start with just medication access and the coaching app
+New Microdose GLP-1Rx program ($99-149/mo), low-dose GLP-1 + biomarker monitoring for sensitive users
+Insurance accepted for qualifying plans, can significantly reduce out-of-pocket costs on brand-name meds
+Industry-leading behavioral coaching app with years of psychology-based weight loss methodology

Cons

−Tiered pricing creates confusion, $69, $99-149, or $149-349 depending on tier
−Full GLP-1Rx program requires 12-week subscription ($149 intro rate applies only for the first few weeks)
−Medication costs on the $69 tier are out-of-pocket, the low tier price is just the platform
−App coaching still requires real engagement, skip-prone users waste the behavioral value

TMates

Pros

+Clinical-service-only path to brand Wegovy and Zepbound at $99/mo, prescription goes to patient's pharmacy (you fill separately using insurance or cash)
+Steep multi-month commitment discounts on compounded sema, $158/mo on 12-month plan ($1,900 upfront) vs $249/mo month-to-month
+Same price at all dose levels for compounded, no cost escalation as you titrate up
+Phentermine available at $149/mo for patients who benefit from a different appetite-suppressant approach

Cons

−The $99/mo Wegovy/Zepbound tier is the clinical service only. Medication is billed separately at your pharmacy (can be $1,000+/mo cash without insurance). Choose this tier when your insurance covers the drug itself.
−The best compounded rates require prepayment: $1,050 upfront for 6 months, $1,900 for 12. Start at $249 month-to-month if you want to test fit first.
−The intake is a 90-second quiz. Fast, but lighter screening than competitors with full medical intakes. Better suited to patients who already know GLP-1 basics.
−TMates prescribes brand-name but does not dispense it, and is not affiliated with Novo Nordisk (Wegovy) or Eli Lilly (Zepbound). Your own pharmacy fills the Rx.

Our Verdict

TMates edges out Noom Med with a score of 7.8/10 vs 7.4/10. If budget is your priority, Noom Med starts at $99/mo compared to TMates's $158/mo. Choose Noom Med if you want: users who want a tiered entry into glp-1 care, from $99/mo microdose all-in (low-dose + biomarkers + coaching) up to a full $349/mo medication + coaching program. Choose TMates if you want: users who want commitment-discount pricing on compounded glp-1s ($158-$249/mo, medication included) or a $99/mo clinical path to brand wegovy or zepbound filled at their own pharmacy.

Still undecided? Editor's Featured Pick

Yucca Health

$146/mo · 7.7/10 · Compounded

If neither Noom Med nor TMates feels like the right fit, our featured pick across all 52 GLP-1 telehealth providers is Yucca Health. It is not the highest-scored provider in our full rankings. We feature it for its low-friction value: a flat $146/mo that stays the same at every dose.

Visit Yucca Health→Read our full Yucca Health review